ArticleBioinformatics (Oxford, England)2026
EXPLANA: a user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Trial
- Altered Tonsillar Microbiome in Children with Down Syndrome and Obstructive Sleep Apnea.bioRxiv : the preprint server for biology · 2026Article
- Agrarian Diet Improves Metabolic Health in HIV-positive Men withResearch square · 2024Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
motivationLongitudinal microbiome studies (LMS) are increasingly common but have analytic challenges including nonindependent data requiring mixed-effects models. Furthermore, large amounts of data motivate exploratory analysis to identify factors related to outcome variables. Although change analysis (i.e. calculating feature changes between timepoints) can be powerful, how to best conduct these analyses is often unclear. For example, observational LMS measurements show natural fluctuations, so baseline might not be a reference of primary interest, whereas for interventional LMS, baseline is typically a key reference point, often indicating the start of treatment.
resultsTo address these challenges, a feature selection workflow, called EXPLANA (EXPLoratory ANAlysis), was developed for LMS that supports numerical and categorical data, and also accommodates cross-sectional studies. Machine learning methods were combined with different types of change calculations and downstream interpretation methods to identify statistically meaningful variables and explain their relationship to outcomes. EXPLANA generates an interactive report that textually and graphically summarizes methods and results. EXPLANA had good performance on simulated longitudinal data, with a balanced accuracy score of 0.91 (range: 0.79-1.00, SD = 0.05), outperformed an existing tool, QIIME 2 feature-volatility (balanced accuracy: 0.95 versus 0.56) and identified novel order-dependent categorical feature changes (e.g. different effect for A_B versus B_A). EXPLANA is broadly applicable and simplifies analytics for identifying features related to outcomes of interest. AVAILABILITY AND IMPLEMENTATION: Software is available at https://github.com/JTFouquier/explana and https://zenodo.org/records/17478745 (10.5281/zenodo.17478744). Documentation and demos are available at www.explana.io.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.